| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 148, 1905-1914, Copyright © 1996 by American Society for Investigative Pathology
REGULAR ARTICLES |
BM van der Leede, J Geertzema, TM Vroom, D Decimo, Y Lutz, PT van der Saag and B van der Burg
Hubrecht Laboratory, Netherlands Institute for Developmental Biology, Utrecht, The Netherlands.
Retinoids are known to prevent mammary carcinogenesis in rodents and inhibit the growth of human breast cancer cells in vitro. Previously we demonstrated that retinoid inhibition of proliferation of human breast cancer cell lines is largely mediated by retinoic acid receptor (RAR)- alpha. In this study we describe for the first time the histological distribution of RAR-alpha in 33 breast lesion specimens as determined by immunostaining with RAR-alpha antibody. Nuclear staining was observed in tumor tissue and normal portions of the breast samples. Connective tissue exhibited relative uniform staining, whereas a wide range of RAR-alpha expression was found in the epithelial tumor cells. RAR-alpha protein was expressed at significantly higher levels in tumors with greater proliferative activity as determined by immunostaining with Ki-67 antibody. This suggests that RAR-alpha expression may be altered with tumor progression. Although a positive correlation between RAR-alpha mRNA levels and estrogen receptor status of breast tumors has previously been documented, we did not find such a relationship at the protein level. As RAR-alpha plays a major role in retinoid-mediated growth inhibition of human breast cancer cell in vitro, our findings suggest that patients with highly proliferating tumors could be responsive to retinoid independently of their responsiveness to (anti)-estrogens.
This article has been cited by other articles:
 |
|
 |
|
  N. Chalabi, L. Delort, S. Satih, P. Dechelotte, Y.-J. Bignon, and D. J. Bernard-Gallon Immunohistochemical Expression of RAR{alpha}, RAR{beta}, and Cx43 in Breast Tumor Cell Lines After Treatment With Lycopene and Correlation With RT-QPCR J. Histochem. Cytochem., September 1, 2007; 55(9): 877 - 883. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. C. Kaiser, M. Korner, A. Kappeler, and S. Aebi Retinoid receptors in ovarian cancer: expression and prognosis Ann. Onc., September 1, 2005; 16(9): 1477 - 1487. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Triano, L. B. Slusher, T. A. Atkins, J. T. Beneski, S. A. Gestl, R. Zolfaghari, R. Polavarapu, E. Frauenhoffer, and J. Weisz Class I Alcohol Dehydrogenase Is Highly Expressed in Normal Human Mammary Epithelium but not in Invasive Breast Cancer: Implications for Breast Carcinogenesis Cancer Res., June 15, 2003; 63(12): 3092 - 3100. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Lotan Aberrant Expression of Retinoid Receptors and Lung Carcinogenesis J Natl Cancer Inst, June 16, 1999; 91(12): 989 - 991. [Full Text] [PDF]
|
|
|
|
 |
|
 C. D. Katsetos, I. Stadnicka, J. C. Boyd, H. Ehya, S. Zheng, C. M. Soprano, H. S. Cooper, A. S. Patchefsky, D. R. Soprano, and K. J. Soprano Cellular Distribution of Retinoic Acid Receptor-{alpha} Protein in Serous Adenocarcinomas of Ovarian, Tubal, and Peritoneal Origin : Comparison with Estrogen Receptor Status Am. J. Pathol., August 1, 1998; 153(2): 469 - 480. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-s. Piao, H. Peltoketo, A. Jouppila, and R. Vihko Retinoic Acids Increase 17{beta}-Hydroxysteroid Dehydrogenase Type 1 Expression in JEG-3 and T47D Cells, but the Stimulation Is Potentiated by Epidermal Growth Factor, 12-O-Tetradecanoylphorbol-13-Acetate, and Cyclic Adenosine 3',5'-Monophosphate Only in JEG-3 Cells Endocrinology, March 1, 1997; 138(3): 898 - 904. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
